These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31785112)

  • 1. Fatty acids and recurrence of major depressive disorder: combined analysis of two Dutch clinical cohorts.
    Thesing CS; Lok A; Milaneschi Y; Assies J; Bockting CLH; Figueroa CA; Giltay EJ; Penninx BWJH; Ruhé HG; Schene AH; Bot M; Mocking RJT
    Acta Psychiatr Scand; 2020 Apr; 141(4):362-373. PubMed ID: 31785112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
    Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
    Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective Study.
    Hamazaki K; Matsuoka YJ; Yamaji T; Sawada N; Mimura M; Nozaki S; Shikimoto R; Tsugane S
    Sci Rep; 2021 Feb; 11(1):4003. PubMed ID: 33597590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
    Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.
    Chhetry BT; Hezghia A; Miller JM; Lee S; Rubin-Falcone H; Cooper TB; Oquendo MA; Mann JJ; Sublette ME
    J Psychiatr Res; 2016 Apr; 75():65-74. PubMed ID: 26802812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis.
    Luo XD; Feng JS; Yang Z; Huang QT; Lin JD; Yang B; Su KP; Pan JY
    BMC Psychiatry; 2020 May; 20(1):248. PubMed ID: 32434488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
    Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
    Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
    Liu JJ; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
    J Clin Psychiatry; 2013 Jul; 74(7):732-8. PubMed ID: 23945451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.
    Berger ME; Smesny S; Kim SW; Davey CG; Rice S; Sarnyai Z; Schlögelhofer M; Schäfer MR; Berk M; McGorry PD; Amminger GP
    Transl Psychiatry; 2017 Aug; 7(8):e1220. PubMed ID: 28850110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression.
    Jadoon A; Chiu CC; McDermott L; Cunningham P; Frangou S; Chang CJ; Sun IW; Liu SI; Lu ML; Su KP; Huang SY; Stewart R
    J Affect Disord; 2012 Feb; 136(3):918-25. PubMed ID: 22113178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
    Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
    Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index.
    Baghai TC; Varallo-Bedarida G; Born C; Häfner S; Schüle C; Eser D; Rupprecht R; Bondy B; von Schacky C
    J Clin Psychiatry; 2011 Sep; 72(9):1242-7. PubMed ID: 21208589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.
    Forouhi NG; Imamura F; Sharp SJ; Koulman A; Schulze MB; Zheng J; Ye Z; Sluijs I; Guevara M; Huerta JM; Kröger J; Wang LY; Summerhill K; Griffin JL; Feskens EJ; Affret A; Amiano P; Boeing H; Dow C; Fagherazzi G; Franks PW; Gonzalez C; Kaaks R; Key TJ; Khaw KT; Kühn T; Mortensen LM; Nilsson PM; Overvad K; Pala V; Palli D; Panico S; Quirós JR; Rodriguez-Barranco M; Rolandsson O; Sacerdote C; Scalbert A; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
    PLoS Med; 2016 Jul; 13(7):e1002094. PubMed ID: 27434045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study.
    Schaakxs R; Comijs HC; Lamers F; Kok RM; Beekman ATF; Penninx BWJH
    Lancet Psychiatry; 2018 Jul; 5(7):581-590. PubMed ID: 29887519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.
    Jiang W; Oken H; Fiuzat M; Shaw LK; Martsberger C; Kuchibhatla M; Kaddurah-Daouk R; Steffens DC; Baillie R; Cuffe M; Krishnan R; O'Connor C;
    J Cardiovasc Transl Res; 2012 Feb; 5(1):92-9. PubMed ID: 22042636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Mocking RJ; Verburg HF; Westerink AM; Assies J; Vaz FM; Koeter MW; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: A longitudinal study within the prospective NICHD Fetal Growth Studies.
    Zhu Y; Li M; Rahman ML; Hinkle SN; Wu J; Weir NL; Lin Y; Yang H; Tsai MY; Ferrara A; Zhang C
    PLoS Med; 2019 Sep; 16(9):e1002910. PubMed ID: 31518348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression.
    Ter Horst DM; Schene AH; Figueroa CA; Assies J; Lok A; Bockting CLH; Ruhé HG; Mocking RJT
    Psychoneuroendocrinology; 2019 Feb; 100():203-212. PubMed ID: 30388594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional longitudinal associations of omega-3 polyunsaturated fatty acid plasma levels with depressive disorders.
    Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
    J Psychiatr Res; 2020 May; 124():1-8. PubMed ID: 32087424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.
    Otoki Y; Hennebelle M; Levitt AJ; Nakagawa K; Swardfager W; Taha AY
    Lipids; 2017 Jun; 52(6):559-571. PubMed ID: 28439746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.